Format

Send to

Choose Destination
Precis Med (Bangalore). 2016;1(1):18-33. Epub 2016 Aug 1.

THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS.

Author information

1
Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA; Departments of Psychiatry & Behavioral Sciences, Keck School of Medicine of USC, Los Angeles, CA, USA; Department of Clinical Neurology, PATH Foundation NY, New York, NY, USA; Human Integrated Services Unit, University of Vermont Centre for Clinical & Translational Science, College of Medicine, Burlington, VT, USA; Division of Addiction Services, Dominion Diagnostics, LLC., North Kingstown, RI, USA; Division of Neuroscience-based Therapy, Summit Estate Recovery Center, Los Gatos, CA, USA; The Shores Treatment & Recovery, Port Saint Lucie, FL, USA; Department of Precision Medicine, IGENE, LLC., Austin, TX, USA; Division of Nutrigenomics, LaVitaRDS, Draper, UT, USA; Institute of Psychology, Eötvös Loránd University Budapest, HUNGARY.
2
Victory Nutrition International, Lederoch, PA, USA.
3
Department of Clinical Neurology, PATH Foundation NY, New York, NY, USA.
4
The Shores Treatment & Recovery, Port Saint Lucie, FL, USA.
5
Division of Nutrigenomics, LaVitaRDS, Draper, UT, USA.
6
Institute of Psychology, Eötvös Loránd University Budapest, HUNGARY.
7
Department of Psychiatry, Laboratory of Molecular and Functional Imaging, University at Minnesota, Minneapolis, MN, USA.

Abstract

DNA Customization of nutraceutical products is here. In the truest sense, "Gene Guided Precision Nutrition" and KB220 variants (a complex mixture of amino-acids, trace metals, and herbals) are the pioneers and standard-bearers for a state of the art DNA customization. Findings by both, Kenneth Blum, Ph.D. and Ernest Noble, Ph.D. concerning the role of genes in shaping cravings and pleasure- seeking, opened the doors to comprehension of how genetics control our actions and effect our mental and physical health. Moreover, technology that is related to KB220 variants in order to reduce or eradicate excessive cravings by influencing gene expression is a cornerstone in the pioneering of the practical applications of nutrigenomics. Continuing discoveries have been an important catalyst for the evolution, expansion, and scientific recognition of the significance of nutrigenomics and its remarkable contributions to human health. Neuro-Nutrigenomics is now a very important field of scientific investigation that offers great promise to improving the human condition. In the forefront is the development of the Genetic Addiction Risk Score (GARS), which unlike 23andMe, has predictive value for the severity of drug and alcohol abuse as well as other non-substance related addictive behaviors. While customization of neuronutrients has not yet been commercialized, there is emerging evidence that in the future, the concept will be developed and could have a significant impact in addiction medicine.

KEYWORDS:

DNA Customization; GARS; Nutraceuticals; Pro-Dopamine regulation (KB220 variants) Reward Deficiency Solution Sustem

PMID:
28066828
PMCID:
PMC5210211

Conflict of interest statement

Kenneth Blum, PhD is the holder of a number of US and Foreign patents issued and pending related to Nutrigenomics and Nutraceuticals. Together with IGENE LLC., a developmental agreement is being established with Body/Sync Inc. for the commercialization of the Genetic Addiction Risk Score (GARS)™ with a sales license to Dominion Diagnostics, LLC. Kenneth Blum is a paid consultant (Chief Scientific Advisor) of Dominion Diagnostics, LLC, and is President& CEO of IGENE, LLC. Dr. Blum is a member of the scientific advisory board of Dominion Diagnostics, LLC and Rivermend Health. Dr. Blum is Chief Scientific Officer of LaVitaRDS. Dr. Blum serves as Neuroscience advisor to Summit Estates Recovery Center and The Shores Treatment & Recovery Center. Drs. Blum (Chairman), Badgaiyan, Thanos and Febo are members of LaVitaRDS Scientific Advisory Board. Dr. Blum is also the Scientific Director of Path Foundation NY. The authors state that there are no other conflicts of interest.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center